Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Endogenous opiates block dopamine inhibition of prolactin secretion in vitro

Abstract

OPIATES stimulate prolactin secretion in vivo; plasma prolactin levels are increased by morphine administration in normal1 and steroid-primed male rats2, as well as in immature3 and oestrogen-treated female rats4. Met-enkephalin and β-endorphin were also stimulatory1–6 as were enkephalin analogues3,7,8. Naloxone or naltrexone, specific opiate antagonists, reduce basal prolactin levels when given alone1,3,9, and block, at least partially, the effect of opiate agonists1–4,7,8. None of these drugs is active in vitro when tested alone on anterior pituitaries3 or dispersed pituitary cells2,4. However, as we have previously shown in a preliminary experiment, the inhibitory effect of dopamine on prolactin secretion in vitro was antagonised by the addition of morphine to the incubation medium10. In the present work, we have attempted to clarify further the mode of interaction of opiates with prolactin secretion. We confirmed that morphine, Met-enkephalin and β-endorphin do not affect the spontaneous release of prolactin in vitro, but found that they suppress the inhibitory effect of dopamine on prolactin release. We have also characterised the specificity and the kinetics of this interaction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Bruni, G. F., Van Vugt, D., Marshall, S. & Meites, J. Life Sci. 21, 461–466 (1977).

    Article  CAS  PubMed  Google Scholar 

  2. Rivier, C., Vale, W., Ling, N., Brown, M. & Guillemin, R. Endocrinology 100, 238–241 (1977).

    Article  CAS  PubMed  Google Scholar 

  3. Shaar, C. J., Frederickson, C. A., Dininger, N. B. & Jackson, L. Life Sci. 21, 853–860 (1977).

    Article  CAS  PubMed  Google Scholar 

  4. Rivier, C., Brown, M. & Vale, W. Endocrinology 100, 751–754 (1977).

    Article  CAS  PubMed  Google Scholar 

  5. Dupont, A., Cusan, L., Labrie, F., Coy, D. H. & Li, C. H. Biochem. biophys. Res. Commun. 75, 76–82 (1977).

    Article  CAS  PubMed  Google Scholar 

  6. Chihara, K., Arimura, A., Coy, D. H. & Schally, A. V. Endocrinology 102, 281–290 (1978).

    Article  CAS  PubMed  Google Scholar 

  7. Lien, E. L., Clark, D. E. & McGregor, W. H. FEBS Lett. 88, 201–208 (1978).

    Article  Google Scholar 

  8. Meltzer, W. Y., Miller, R. J., Fessler, R. G., Simonovic, M. & Fang, V. S. Life Sci. 22, 1931–1938 (1978).

    Article  CAS  PubMed  Google Scholar 

  9. Grandison, L. & Guidotti, I. Nature 270, 357–358 (1977).

    Article  ADS  CAS  PubMed  Google Scholar 

  10. Enjalbert, A. et al. Eur. J. Pharmac. 53, 211–212 (1979).

    Article  CAS  Google Scholar 

  11. Pathy, A., Graf, L., Kenessey, A., Szekely, G. I. & Bajusz, S. Biochem. biophys. Res. Commun. 79, 254–259 (1977).

    Article  Google Scholar 

  12. Enjalbert, A., Moos, F., Carbonell, L., Priam, M. & Kordon, C. Neuroendocrinology 24, 147–161 (1977).

    Article  CAS  PubMed  Google Scholar 

  13. Parker, R. B. & Wand, D. R. Eur. J. Pharmac. exp. Ther. 177 1–12.

  14. Lineweaver, H. & Burk, D. J. Am. chem. Soc. 56, 658–666 (1934).

    Article  CAS  Google Scholar 

  15. Höllt, V. & Hertz, A. in Opiates and Endogenous Opioid Peptides (ed. Kosterlitz, H. W.) 345–352 (Elsevier, Amsterdam, 1976).

    Google Scholar 

  16. Ferland, L., Fuxe, K., Enroth, P., Gustaffson, J. A. & Skett, P. Eur. J. Pharmac. 43, 89–90 (1977).

    Article  CAS  Google Scholar 

  17. Caron, M. G. et al. J. biol. Chem. 253, 2244–2253 (1978).

    CAS  PubMed  Google Scholar 

  18. Czlonkowski, A., Höllt, V. & Herz, A. Life Sci. 22, 953–962 (1978).

    Article  CAS  PubMed  Google Scholar 

  19. Pollard, H., Llorens-Cortes, C. & Schwartz, J. C. Nature 268, 745–747 (1977).

    Article  ADS  CAS  PubMed  Google Scholar 

  20. Rotsztejn, W. H., Drouva, S. V., Pattou, E. & Kordon, C. Nature 274, 281–282 (1978).

    Article  ADS  CAS  PubMed  Google Scholar 

  21. Jacob, J. J. C. & Ramabadran, K. Br. J. Pharmac. 64, 91–98 (1978).

    Article  CAS  Google Scholar 

  22. Dingledine, R., Iversen, L. L. & Breuker, E. Eur. J. Pharmac. 47, 19–27 (1978).

    Article  CAS  Google Scholar 

  23. Lord, J. A. H., Waterfield, A. A., Hughes, J. & Kosterlitz, H. W. in Opiates and Endogenous Opioid Peptides (ed. Kosterlitz, H. W.) 275–280 (Elsevier, Amsterdam, 1976).

    Google Scholar 

  24. Della Bella, D., Casacci, F. & Sassi, A. Adv. biochem. Psychopharmac. 18, 271–278 (1978).

    CAS  Google Scholar 

  25. Simantov, R. & Snyder, S. H. Brain Res. 124, 178–184 (1977).

    Article  CAS  PubMed  Google Scholar 

  26. Van Vugt, D. A., Bruni, G. F. & Meites, J. Life Sci. 22, 85–90 (1977).

    Article  Google Scholar 

  27. Ferland, L., Kledzik, G. S., Cusan, L. & Labrie, F. Molec. cell. Endocr. 12, 267–272 (1978).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

ENJALBERT, A., RUBERG, M., ARANCIBIA, S. et al. Endogenous opiates block dopamine inhibition of prolactin secretion in vitro. Nature 280, 595–597 (1979). https://doi.org/10.1038/280595a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/280595a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing